NCT01645189View on ClinicalTrials.gov

Safety and Efficacy of Hunterase

PHASE3CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions
Hunter Syndrome
Interventions
BIOLOGICAL

Hunterase

once weekly, 0.5mg/kg IV infusion

Trial Locations (1)

Unknown

Samsug Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Green Cross Corporation

INDUSTRY

NCT01645189 - Safety and Efficacy of Hunterase | Biotech Hunter | Biotech Hunter